Clinical Trial Update: Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating magrolimab added to venetoclax and azacitidine versus placebo in adults with Acute Myeloid Leukemia was terminated. Results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Azacitidine (Vidaza) (azacitidine)
• Magrolimab (magrolimab)
• Venetoclax (Venclexta) (venetoclax)

Snippet

Sponsor: Gilead Sciences | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: TERMINATED | Results posted: 2025-04-04